Search - tctmd.com

Displaying 861 - 880 of 2776

Sort: Relevancy | Date

News Features

Year in Review: Payment Fights, Wearables, Burnout Defined Cardiology Practice in 2019

Caitlin E. Cox

December 17, 2019

News Features

Year in Review: In Imaging, Interventional CT, Physiology, and #SoMe Advance in 2019

Yael L. Maxwell

December 13, 2019

News Features

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

L.A. McKeown

December 12, 2019

News Daily News

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Michael O'Riordan

December 10, 2019

News Opinion Editor's Corner

ISCHEMIA Questions? Some Answers From David Maron

Shelley Wood

December 09, 2019

News Daily News

Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights

Shelley Wood

December 02, 2019

News Daily News

Long-term Watchman Data Reassure: CAP and CAP2 Registries

Michael O'Riordan

December 02, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2019

Shelley Wood

November 29, 2019

News Daily News

Uninformed Consent? Most Patients Misunderstand True Benefits of PCI

Michael O'Riordan

November 29, 2019

News Conference News VEITH 2019

Endovascular Office-Based Labs: Balancing Upsides Against Potential for Abuse

L.A. McKeown

November 28, 2019

News Conference News VEITH 2019

Uproar Continues Over UK NICE Guidelines Restricting EVAR for AAA

L.A. McKeown

November 26, 2019

News Conference News VEITH 2019

More Real-world Data Support Safety of Paclitaxel-Based Devices in PAD

L.A. McKeown

November 22, 2019

News Conference News PCR London Valves 2019

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Michael O'Riordan

November 20, 2019

News Conference News AHA 2019

Inclisiran in FH: Safe, Cuts LDL in This Challenging Group

Yael L. Maxwell

November 19, 2019

News Conference News AHA 2019

Dapagliflozin Has Benefits Across Heart Failure Subgroups

Todd Neale

November 17, 2019

News Conference News AHA 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

Todd Neale

November 17, 2019

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

News Conference News AHA 2019

More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA

Michael O'Riordan

November 14, 2019

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Conference News VIVA 2019

Nearly 1 Year Later, Endovascular Community Continues to Struggle With Paclitaxel

L.A. McKeown

November 08, 2019

Advertisement

Year in Review: Payment Fights, Wearables, Burnout Defined Cardiology Practice in 2019

Year in Review: In Imaging, Interventional CT, Physiology, and #SoMe Advance in 2019

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

ISCHEMIA Questions? Some Answers From David Maron

Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights

Long-term Watchman Data Reassure: CAP and CAP2 Registries

TCTMD’s Top 10 Most Popular Stories for November 2019

Uninformed Consent? Most Patients Misunderstand True Benefits of PCI

Endovascular Office-Based Labs: Balancing Upsides Against Potential for Abuse

Uproar Continues Over UK NICE Guidelines Restricting EVAR for AAA

More Real-world Data Support Safety of Paclitaxel-Based Devices in PAD

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Inclisiran in FH: Safe, Cuts LDL in This Challenging Group

Dapagliflozin Has Benefits Across Heart Failure Subgroups

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Nearly 1 Year Later, Endovascular Community Continues to Struggle With Paclitaxel

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content